BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers

  March 18, 2026

   · 

  11 min read
• Press Releases

  Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)

  March 18, 2026

   · 

  7 min read
• Press Releases

  Synthekine Announces AACR 2026 Oral Presentation of Updated Phase 1a/1b Clinical and Translational Data for STK‑012 in First‑Line Nonsquamous NSCLC with Features of Immunotherapy Resistance

  March 18, 2026

   · 

  2 min read
• Press Releases

  Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

  March 18, 2026

   · 

  5 min read
• Press Releases

  Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

  March 18, 2026

   · 

  4 min read
• Press Releases

  Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026

  March 18, 2026

   · 

  4 min read
• Press Releases

  SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting

  March 18, 2026

   · 

  2 min read
• Press Releases

  Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026

  March 18, 2026

   · 

  2 min read
• Press Releases

  Pheast Therapeutics to Present Initial Phase 1a Clinical Data and Two New Preclinical Studies of PHST001, a Novel Anti-CD24 Antibody, at AACR 2026

  March 18, 2026

   · 

  3 min read
• Press Releases

  Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier™ Platform at AACR Annual Meeting 2026

  March 18, 2026

   · 

  5 min read